Low vs standard dose of recombinant tissue plasminogen activator in treating East Asian patients with acute ischemic stroke.

@article{Dharmasaroja2011LowVS,
  title={Low vs standard dose of recombinant tissue plasminogen activator in treating East Asian patients with acute ischemic stroke.},
  author={Permphan Dharmasaroja and Junya Pattaraarchachai},
  journal={Neurology India},
  year={2011},
  volume={59 2},
  pages={180-4}
}
BACKGROUND Intravenous recombinant tissue plasminogen activator (rtPA) has been approved to treat eligible patients with acute ischemic stroke within 4.5 hours of onset. The rationale for using a lower dose in Asian patients came from concerns about intracerebral hemorrhage because of the racial differences in blood coagulation-fibrinolysis factors. AIM… CONTINUE READING